JP2017503527A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017503527A5 JP2017503527A5 JP2016565119A JP2016565119A JP2017503527A5 JP 2017503527 A5 JP2017503527 A5 JP 2017503527A5 JP 2016565119 A JP2016565119 A JP 2016565119A JP 2016565119 A JP2016565119 A JP 2016565119A JP 2017503527 A5 JP2017503527 A5 JP 2017503527A5
- Authority
- JP
- Japan
- Prior art keywords
- prostate cancer
- individual
- collection
- genes
- expression level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010060862 Prostate cancer Diseases 0.000 claims 15
- 230000014509 gene expression Effects 0.000 claims 14
- 102100004951 ABCC11 Human genes 0.000 claims 8
- 101710025668 ABCC11 Proteins 0.000 claims 8
- -1 F10 Proteins 0.000 claims 8
- 102100016819 MMP11 Human genes 0.000 claims 8
- 101700081066 MMP11 Proteins 0.000 claims 8
- 102100018287 NKX2-1 Human genes 0.000 claims 8
- 101710012901 NKX2-1 Proteins 0.000 claims 8
- 102100013924 ZYG11A Human genes 0.000 claims 8
- 101710010193 ZYG11A Proteins 0.000 claims 8
- 102100010222 CLEC4F Human genes 0.000 claims 6
- 101710026581 CLEC4F Proteins 0.000 claims 6
- 102100014758 CPVL Human genes 0.000 claims 6
- 101700061084 CPVL Proteins 0.000 claims 6
- 102100013174 HCAR1 Human genes 0.000 claims 6
- 101710027718 MAGEE1 Proteins 0.000 claims 6
- 102100010182 MYBPC1 Human genes 0.000 claims 6
- 101710035667 MYBPC1 Proteins 0.000 claims 6
- 102100010862 OAS2 Human genes 0.000 claims 6
- 101700086999 OAS2 Proteins 0.000 claims 6
- 102100007398 PGC Human genes 0.000 claims 6
- 101710042671 PGC Proteins 0.000 claims 6
- 102100015936 UPK1A Human genes 0.000 claims 6
- 101700033542 UPK1A Proteins 0.000 claims 6
- 101700060191 pgaC Proteins 0.000 claims 6
- 102100019000 ABLIM1 Human genes 0.000 claims 4
- 101710029207 ABLIM1 Proteins 0.000 claims 4
- 102000017904 ADRA2C Human genes 0.000 claims 4
- 108060003351 ADRA2C Proteins 0.000 claims 4
- 102100016632 DUOX1 Human genes 0.000 claims 4
- 101700087024 DUOX1 Proteins 0.000 claims 4
- 102100019242 KCNA3 Human genes 0.000 claims 4
- 101700057850 KCNA3 Proteins 0.000 claims 4
- 108010006746 KCNQ2 Potassium Channel Proteins 0.000 claims 4
- 102000005453 KCNQ2 Potassium Channel Human genes 0.000 claims 4
- 102100019729 PCBP3 Human genes 0.000 claims 4
- 101700052267 PCBP3 Proteins 0.000 claims 4
- 102100015932 UPK3B Human genes 0.000 claims 4
- 101700021850 UPK3B Proteins 0.000 claims 4
- 102100010491 GLDC Human genes 0.000 claims 3
- 101710037084 GLDC Proteins 0.000 claims 3
- 239000012472 biological sample Substances 0.000 claims 3
- 102100014032 DUOXA1 Human genes 0.000 claims 2
- 101710005148 DUOXA1 Proteins 0.000 claims 2
- 102100009644 LDAH Human genes 0.000 claims 2
- 108060000074 LDAH Proteins 0.000 claims 2
- 102100005452 TUBB2B Human genes 0.000 claims 2
- 101710034506 TUBB2B Proteins 0.000 claims 2
- 239000000090 biomarker Substances 0.000 claims 2
- 238000007477 logistic regression Methods 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 206010069754 Acquired gene mutation Diseases 0.000 claims 1
- 101700009265 BUD31 Proteins 0.000 claims 1
- 101710015670 CHI17 Proteins 0.000 claims 1
- 230000007067 DNA methylation Effects 0.000 claims 1
- 102100006067 EDARADD Human genes 0.000 claims 1
- 101710005429 EDARADD Proteins 0.000 claims 1
- 108060005549 NPR3 Proteins 0.000 claims 1
- 102000002452 NPR3 Human genes 0.000 claims 1
- 229920000029 PCA3 Polymers 0.000 claims 1
- 102100018386 PRTN3 Human genes 0.000 claims 1
- 101700029041 PRTN3 Proteins 0.000 claims 1
- 102100012127 ZBTB12 Human genes 0.000 claims 1
- 101710006058 ZBTB12 Proteins 0.000 claims 1
- 210000004602 germ cell Anatomy 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
Claims (15)
- 個体における前立腺がんの進行を予測するための方法であって、
(a)前記個体から採取された生物学的試料からのサイン遺伝子のコレクションの発現レベルを受け取る工程であって、サイン遺伝子の前記コレクションが
NKX2−1、UPK1A、ADRA2C、ABCC11、MMP11、CPVL、ZYG11A、CLEC4F、OAS2、PGC、UPK3B、PCBP3、ABLIM1、EDARADD、GPR81、MYBPC1、F10、KCNA3、GLDC、KCNQ2、RAPGEF1、TUBB2B、MB、DUOXA1、C2orf43、DUOX1、PCA3およびNPR3からなる群から選択される少なくとも2つの遺伝子、または
NKX2−1、UPK1A、ABCC11、MMP11、CPVL、ZYG11A、CLEC4F、OAS2、PGC、UPK3B、PCBP3、EDARADD、GPR81、MYBPC1、KCNA3、GLDC、KCNQ2、RAPGEF1、TUBB2B、MB、DUOXA1、C2orf43、DUOX1、およびNPR3からなる群から選択される少なくとも1つの遺伝子
を含む、前記工程;
(b)発現レベルを、サイン遺伝子の前記コレクションの発現レベルを前立腺がん進行と関連づける予測モデルに適用する工程;および
(c)前記予測モデルのアウトプットを評価して、前記個体における前立腺がんの進行を予測する工程
を含む方法。 - サイン遺伝子の前記コレクションが
NKX2−1、UPK1A、ADRA2C、ABCC11、MMP11、CPVL、ZYG11A、CLEC4F、OAS2、およびPGCからなる群から選択される少なくとも2つの遺伝子、または
ZYG11A、MMP11、MYBPC1、DUOX1、EDARADD、PGC、GPR81、NKX2−1、ABLIM1、およびABCC11からなる群から選択される少なくとも2つの遺伝子
を含む、請求項1に記載の方法。 - 予測モデルの前記アウトプットが、
(I)個体が前立腺がんのための処置を受けた後、前記個体における前立腺がんの臨床的再発の見込み、および
(II)個体が前立腺がんのための処置を受けた後、前記個体における前立腺がんの生化学的再発の見込み
の1つまたは両方を予測する、請求項1または2に記載の方法。 - グリーソンスコア、前立腺がんのための外科手術の年、手術前PSAレベル、および年齢の少なくとも1つを予測モデルに適用する工程であって、予測モデルがグリーソンスコア、前立腺がんのための外科手術の年、手術前PSAレベル、および年齢の少なくとも1つを前立腺がん進行に関連づける前記工程をさらに含む、請求項1から3までのいずれかに記載の方法。
- 前記サイン遺伝子の遺伝子発現レベルを1つまたは複数の他のバイオマーカーと組み合わせて、前記個体における前立腺がんの進行を予測する工程をさらに含む、請求項1から4までのいずれかに記載の方法。
- 1つまたは複数の他のバイオマーカーが生殖細胞系列変異、体細胞変異、DNAメチル化マーカー、タンパク質マーカー、およびその任意の組合せからなる群から選択される、請求項5に記載の方法。
- サイン遺伝子のコレクションの発現レベルが複数回測定された遺伝子発現レベルを含む、請求項1から6までのいずれかに記載の方法。
- 複数回測定された遺伝子発現レベルの動態を使用して、前記個体における前立腺がんの進行を予測する工程をさらに含む、請求項7に記載の方法。
- 予測モデルのアウトプットを評価して、個体が高リスク群に属するかどうかを決定する工程をさらに含む、請求項1から8までのいずれかに記載の方法。
- サイン遺伝子のコレクションを約1000を超える遺伝子から選択することによって、前記予測モデルを開発する工程をさらに含む、請求項1から9までのいずれかに記載の方法。
- 安定性選択、ロジスティック回帰、またはエラスティックネット正規化ロジスティック回帰を用いた安定性選択を使用して前記予測モデルを開発する工程をさらに含む、請求項1から10までのいずれかに記載の方法。
- サイン遺伝子のコレクションの前記発現レベルを前記予測モデルに適用する工程が、サイン遺伝子のコレクションの安定性順位または予測力順位に従って前記発現レベルに加重値を与える工程を含む、請求項1から11までのいずれかに記載の方法。
- (a)の前に、発現レベルを決定する工程をさらに含む、請求項1から12までのいずれかに記載の方法。
- 個体における前立腺がんの進行を予測するためのシステムであって、
個体から採取された生物学的試料からの核酸の発現レベルを決定するように構成された装置;並びに
(a)前記個体から採取された生物学的試料からのサイン遺伝子のコレクションの発現レベルを受け取ることであって、サイン遺伝子の前記コレクションが
NKX2−1、UPK1A、ADRA2C、ABCC11、MMP11、CPVL、ZYG11A、CLEC4F、OAS2、PGC、UPK3B、PCBP3、ABLIM1、EDARADD、GPR81、MYBPC1、F10、KCNA3、GLDC、KCNQ2、RAPGEF1、TUBB2B、MB、DUOXA1、C2orf43、DUOX1、PCA3およびNPR3からなる群から選択される少なくとも2つの遺伝子、または
NKX2−1、UPK1A、ABCC11、MMP11、CPVL、ZYG11A、CLEC4F、OAS2、PGC、UPK3B、PCBP3、EDARADD、GPR81、MYBPC1、KCNA3、GLDC、KCNQ2、RAPGEF1、TUBB2B、MB、DUOXA1、C2orf43、DUOX1、およびNPR3からなる群から選択される少なくとも1つの遺伝子
を含む、受け取ること;
(b)発現レベルを、サイン遺伝子の前記コレクションの発現レベルを前立腺がん進行と関連づける予測モデルに適用すること;および
(c)前記予測モデルのアウトプットを評価して、前記個体における前立腺がんの進行を予測すること
を含む操作を行うように設計または構成されたハードウェアロジック
を含むシステム。 - サイン遺伝子の前記コレクションが
NKX2−1、UPK1A、ADRA2C、ABCC11、MMP11、CPVL、ZYG11A、CLEC4F、OAS2、およびPGCからなる群から選択される少なくとも2つの遺伝子、または
ZYG11A、MMP11、MYBPC1、DUOX1、EDARADD、PGC、GPR81、NKX2−1、ABLIM1、およびABCC11からなる群から選択される少なくとも2つの遺伝子
を含む、請求項14に記載のシステム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461928361P | 2014-01-16 | 2014-01-16 | |
US61/928,361 | 2014-01-16 | ||
PCT/US2015/011824 WO2015109234A1 (en) | 2014-01-16 | 2015-01-16 | Gene expression panel for prognosis of prostate cancer recurrence |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2017503527A JP2017503527A (ja) | 2017-02-02 |
JP2017503527A5 true JP2017503527A5 (ja) | 2018-03-01 |
JP6666852B2 JP6666852B2 (ja) | 2020-03-18 |
Family
ID=52435027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016565119A Active JP6666852B2 (ja) | 2014-01-16 | 2015-01-16 | 前立腺がん再発の予後に関する遺伝子発現パネル |
Country Status (8)
Country | Link |
---|---|
US (3) | US10364469B2 (ja) |
EP (1) | EP3094747B1 (ja) |
JP (1) | JP6666852B2 (ja) |
CN (2) | CN105917008B (ja) |
AU (3) | AU2015206336B2 (ja) |
CA (1) | CA2935720A1 (ja) |
HK (1) | HK1231515A1 (ja) |
WO (1) | WO2015109234A1 (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105917008B (zh) | 2014-01-16 | 2020-11-27 | 启迪公司 | 用于前列腺癌复发的预后的基因表达面板 |
CN107699564B (zh) * | 2017-10-23 | 2019-09-20 | 中国科学院苏州生物医学工程技术研究所 | 人前列腺癌早期诊断用长链非编码rna序列及其应用 |
US10769783B2 (en) * | 2018-02-09 | 2020-09-08 | Case Western Reserve University | Predicting prostate cancer biochemical recurrence using combined nuclear NF-KB/P65 localization and gland morphology |
US11348239B2 (en) | 2018-05-14 | 2022-05-31 | Tempus Labs, Inc. | Predicting total nucleic acid yield and dissection boundaries for histology slides |
EP3794551A4 (en) | 2018-05-14 | 2022-02-09 | Tempus Labs, Inc. | FRAMEWORK FOR GENERALIZABLE AND INTERPRETABLE DEEP LEARNING FOR PREDICTING MSI FROM HISTOPATHOLOGICAL SLIDE IMAGES |
US10957041B2 (en) | 2018-05-14 | 2021-03-23 | Tempus Labs, Inc. | Determining biomarkers from histopathology slide images |
US11348661B2 (en) | 2018-05-14 | 2022-05-31 | Tempus Labs, Inc. | Predicting total nucleic acid yield and dissection boundaries for histology slides |
US11348240B2 (en) * | 2018-05-14 | 2022-05-31 | Tempus Labs, Inc. | Predicting total nucleic acid yield and dissection boundaries for histology slides |
EP3856903A4 (en) | 2018-09-27 | 2022-07-27 | Grail, LLC | METHYLATION MARKER AND TARGETED METHYLATION PROBE PANEL |
WO2020092808A1 (en) | 2018-10-31 | 2020-05-07 | Regents Of The University Of Minnesota | Methods for predicting a response to bevacizumab or platinum-based chemotherapy or both in patients with ovarian cancer |
GB202406403D0 (en) * | 2019-05-08 | 2024-06-19 | Oxford BioDynamics PLC | Chromosome Conformation Markers of Prostate Cancer and Lymphoma |
CN110706749B (zh) * | 2019-09-10 | 2022-06-10 | 至本医疗科技(上海)有限公司 | 一种基于组织器官分化层次关系的癌症类型预测系统和方法 |
US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
KR102139313B1 (ko) * | 2020-02-27 | 2020-07-29 | 이화여자대학교 산학협력단 | 알츠하이머병 치매 조기 진단을 위한 후성 유전학적 진단 키트 개발 |
KR102139315B1 (ko) * | 2020-02-27 | 2020-07-29 | 이화여자대학교 산학협력단 | Tnfrsf19 유전자의 dna 메틸레이션 변화를 이용한 알츠하이머병 치매 조기진단 마커 |
WO2022147503A1 (en) * | 2020-12-31 | 2022-07-07 | Tempus Labs, Inc. | Predicting total nucleic acid yield and dissection boundaries for histology slides |
WO2023058100A1 (ja) | 2021-10-04 | 2023-04-13 | 国立大学法人 東京大学 | 構造多型の検出方法、プライマーセット及びプライマーセットの設計方法 |
Family Cites Families (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4469863A (en) | 1980-11-12 | 1984-09-04 | Ts O Paul O P | Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof |
US5235033A (en) | 1985-03-15 | 1993-08-10 | Anti-Gene Development Group | Alpha-morpholino ribonucleoside derivatives and polymers thereof |
US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
US5216141A (en) | 1988-06-06 | 1993-06-01 | Benner Steven A | Oligonucleotide analogs containing sulfur linkages |
GB8822228D0 (en) | 1988-09-21 | 1988-10-26 | Southern E M | Support-bound oligonucleotides |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
DE3924454A1 (de) | 1989-07-24 | 1991-02-07 | Cornelis P Prof Dr Hollenberg | Die anwendung von dna und dna-technologie fuer die konstruktion von netzwerken zur verwendung in der chip-konstruktion und chip-produktion (dna chips) |
US5252743A (en) | 1989-11-13 | 1993-10-12 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
US5602240A (en) | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
US5386023A (en) | 1990-07-27 | 1995-01-31 | Isis Pharmaceuticals | Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling |
CA2118806A1 (en) | 1991-09-18 | 1993-04-01 | William J. Dower | Method of synthesizing diverse collections of oligomers |
DE69233087T2 (de) | 1991-11-22 | 2003-12-24 | Affymetrix Inc N D Ges D Staat | Verfahren zur Herstellung von Polymerarrays |
US5324633A (en) | 1991-11-22 | 1994-06-28 | Affymax Technologies N.V. | Method and apparatus for measuring binding affinity |
US5644048A (en) | 1992-01-10 | 1997-07-01 | Isis Pharmaceuticals, Inc. | Process for preparing phosphorothioate oligonucleotides |
DE69333650T2 (de) | 1992-02-19 | 2006-01-12 | The Public Health Research Institute Of The City Of New York, Inc. | Neue anordnungn von oligonukleotiden und ihr nutzen zum sortieren, isolieren, sequenzieren und manipulieren von nukleinsäuren |
US5583211A (en) | 1992-10-29 | 1996-12-10 | Beckman Instruments, Inc. | Surface activated organic polymers useful for location - specific attachment of nucleic acids, peptides, proteins and oligosaccharides |
US5491074A (en) | 1993-04-01 | 1996-02-13 | Affymax Technologies Nv | Association peptides |
US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
US5472672A (en) | 1993-10-22 | 1995-12-05 | The Board Of Trustees Of The Leland Stanford Junior University | Apparatus and method for polymer synthesis using arrays |
US5429807A (en) | 1993-10-28 | 1995-07-04 | Beckman Instruments, Inc. | Method and apparatus for creating biopolymer arrays on a solid support surface |
US6090555A (en) | 1997-12-11 | 2000-07-18 | Affymetrix, Inc. | Scanned image alignment systems and methods |
US5578832A (en) | 1994-09-02 | 1996-11-26 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
US5637684A (en) | 1994-02-23 | 1997-06-10 | Isis Pharmaceuticals, Inc. | Phosphoramidate and phosphorothioamidate oligomeric compounds |
DE69503126T2 (de) | 1994-05-05 | 1998-11-12 | Beckman Instruments Inc | Repetitive oligonukleotide matrix |
US5571639A (en) | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
US5795716A (en) | 1994-10-21 | 1998-08-18 | Chee; Mark S. | Computer-aided visualization and analysis system for sequence evaluation |
US5599695A (en) | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
US5624711A (en) | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US5968740A (en) | 1995-07-24 | 1999-10-19 | Affymetrix, Inc. | Method of Identifying a Base in a Nucleic Acid |
EP0852004B1 (en) | 1995-10-11 | 2011-01-19 | Luminex Corporation | Multiplexed analysis of clinical specimens |
US5658734A (en) | 1995-10-17 | 1997-08-19 | International Business Machines Corporation | Process for synthesizing chemical compounds |
US6022963A (en) | 1995-12-15 | 2000-02-08 | Affymetrix, Inc. | Synthesis of oligonucleotide arrays using photocleavable protecting groups |
WO1997043611A1 (en) | 1996-05-16 | 1997-11-20 | Affymetrix, Inc. | Systems and methods for detection of labeled materials |
US5786146A (en) | 1996-06-03 | 1998-07-28 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
ATE234674T1 (de) | 1996-11-14 | 2003-04-15 | Affymetrix Inc | Chemische amplifizierung zur synthese von musterordnungen |
US6297006B1 (en) | 1997-01-16 | 2001-10-02 | Hyseq, Inc. | Methods for sequencing repetitive sequences and for determining the order of sequence subfragments |
US6327410B1 (en) | 1997-03-14 | 2001-12-04 | The Trustees Of Tufts College | Target analyte sensors utilizing Microspheres |
US6023540A (en) | 1997-03-14 | 2000-02-08 | Trustees Of Tufts College | Fiber optic sensor with encoded microspheres |
US6033860A (en) | 1997-10-31 | 2000-03-07 | Affymetrix, Inc. | Expression profiles in adult and fetal organs |
US6087102A (en) | 1998-01-07 | 2000-07-11 | Clontech Laboratories, Inc. | Polymeric arrays and methods for their use in binding assays |
US6428752B1 (en) | 1998-05-14 | 2002-08-06 | Affymetrix, Inc. | Cleaning deposit devices that form microarrays and the like |
US6287776B1 (en) | 1998-02-02 | 2001-09-11 | Signature Bioscience, Inc. | Method for detecting and classifying nucleic acid hybridization |
JP2002502588A (ja) | 1998-02-06 | 2002-01-29 | アフィメトリックス インコーポレイテッド | 製造プロセスにおける品質管理の方法 |
JP3944996B2 (ja) | 1998-03-05 | 2007-07-18 | 株式会社日立製作所 | Dnaプローブアレー |
US6031078A (en) | 1998-06-16 | 2000-02-29 | Millennium Pharmaceuticals, Inc. | MTbx protein and nucleic acid molecules and uses therefor |
US6277628B1 (en) | 1998-10-02 | 2001-08-21 | Incyte Genomics, Inc. | Linear microarrays |
US6355431B1 (en) | 1999-04-20 | 2002-03-12 | Illumina, Inc. | Detection of nucleic acid amplification reactions using bead arrays |
US20030207295A1 (en) | 1999-04-20 | 2003-11-06 | Kevin Gunderson | Detection of nucleic acid reactions on bead arrays |
ATE553219T1 (de) | 1999-04-20 | 2012-04-15 | Illumina Inc | Erkennung von nukleinsäurereaktionen auf bead- arrays |
EP1990428B1 (en) | 2000-02-07 | 2010-12-22 | Illumina, Inc. | Nucleic acid detection methods using universal priming |
US7582420B2 (en) | 2001-07-12 | 2009-09-01 | Illumina, Inc. | Multiplex nucleic acid reactions |
US7611869B2 (en) | 2000-02-07 | 2009-11-03 | Illumina, Inc. | Multiplexed methylation detection methods |
US6913884B2 (en) | 2001-08-16 | 2005-07-05 | Illumina, Inc. | Compositions and methods for repetitive use of genomic DNA |
US20040121364A1 (en) | 2000-02-07 | 2004-06-24 | Mark Chee | Multiplex nucleic acid reactions |
US7955794B2 (en) | 2000-09-21 | 2011-06-07 | Illumina, Inc. | Multiplex nucleic acid reactions |
US6770441B2 (en) | 2000-02-10 | 2004-08-03 | Illumina, Inc. | Array compositions and methods of making same |
JP2001244419A (ja) * | 2000-02-28 | 2001-09-07 | Hitachi Ltd | 高周波モジュール及び移動体検知モジュール |
US6489606B1 (en) | 2000-04-07 | 2002-12-03 | Cidra Corporation | Bragg grating sensor system with spectral response or code division multiplexing |
EP2100971A3 (en) * | 2000-07-07 | 2009-11-25 | Visigen Biotechnologies, Inc. | Real-time sequence determination |
US20040018491A1 (en) | 2000-10-26 | 2004-01-29 | Kevin Gunderson | Detection of nucleic acid reactions on bead arrays |
KR20040064275A (ko) * | 2001-11-09 | 2004-07-16 | 소스 프리시전 메디슨, 인코포레이티드 | 유전자 발현 프로파일을 이용한 질병의 동정, 모니터링,치료 및 생물학적 상태의 확인 |
US8288641B2 (en) * | 2001-12-27 | 2012-10-16 | Intel Corporation | Portable hand-held music synthesizer and networking method and apparatus |
US20040029151A1 (en) * | 2002-04-09 | 2004-02-12 | Affymetrix, Inc. | Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer |
US7164533B2 (en) | 2003-01-22 | 2007-01-16 | Cyvera Corporation | Hybrid random bead/chip based microarray |
WO2004019276A1 (en) | 2002-08-20 | 2004-03-04 | Cyvera Corporation | Diffraction grating-based optical identification element |
US7441703B2 (en) | 2002-08-20 | 2008-10-28 | Illumina, Inc. | Optical reader for diffraction grating-based encoded optical identification elements |
US20050227252A1 (en) | 2002-08-20 | 2005-10-13 | Moon John A | Diffraction grating-based encoded articles for multiplexed experiments |
EP1575707A1 (en) | 2002-09-12 | 2005-09-21 | Cyvera Corporation | Method and apparatus for aligning elongated microbeads in order to interrogate the same |
WO2004025562A1 (en) | 2002-09-12 | 2004-03-25 | Cyvera Corp. | Method and apparatus for labelling using diffraction grating-based encoded optical identification elements |
US20040259105A1 (en) | 2002-10-03 | 2004-12-23 | Jian-Bing Fan | Multiplex nucleic acid analysis using archived or fixed samples |
US20040219575A1 (en) * | 2002-12-26 | 2004-11-04 | Toomas Neuman | Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
US20050181394A1 (en) | 2003-06-20 | 2005-08-18 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
CA2559801A1 (en) | 2003-10-01 | 2005-04-14 | Cyvera Corporation | Optical reader for diffraction grating-based encoded optical identification elements |
US20060023310A1 (en) | 2004-02-19 | 2006-02-02 | Putnam Martin A | Optical identification element using separate or partially overlapped diffraction gratings |
US7339165B2 (en) | 2004-07-09 | 2008-03-04 | Hamilton Sundstrand Corporation | Dual outlet pyrolyzer for biological agent detection system |
DE602005019791D1 (de) | 2004-11-16 | 2010-04-15 | Illumina Inc | Verfahren und vorrichtung zum lesen von kodierten mikrokugeln |
CA2491067A1 (en) | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
US7914988B1 (en) | 2006-03-31 | 2011-03-29 | Illumina, Inc. | Gene expression profiles to predict relapse of prostate cancer |
US8262900B2 (en) | 2006-12-14 | 2012-09-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
CA2701726A1 (en) | 2007-10-04 | 2009-04-09 | Halcyon Molecular | Sequencing nucleic acid polymers with electron microscopy |
US20120329713A1 (en) * | 2008-02-21 | 2012-12-27 | Klem Robert E | Method for determining likelihood of clinical recurrence or clinically stable disease of prostate cancer after radical prostatectomy |
US20110236903A1 (en) * | 2008-12-04 | 2011-09-29 | Mcclelland Michael | Materials and methods for determining diagnosis and prognosis of prostate cancer |
AU2010248884B2 (en) * | 2009-05-14 | 2015-04-02 | Nestec S.A. | Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapy |
TWM395976U (en) * | 2010-06-30 | 2011-01-01 | Tsung-Hung Wu | Electret electroacoustic transducer |
EP3556870B9 (en) * | 2010-07-27 | 2022-09-28 | Genomic Health, Inc. | Method for using gene expression to determine prognosis of prostate cancer |
CA2827894A1 (en) * | 2011-02-22 | 2012-08-30 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Circulating biomarkers |
CA2838736A1 (en) * | 2011-06-07 | 2012-12-13 | Caris Mpi, Inc. | Molecular profiling for cancer |
MX351626B (es) * | 2012-01-31 | 2017-10-23 | Genomic Health Inc | Algoritmo de perfil de expresion genica y prueba para determinar la prognosis de cancer de prostata. |
US20130323739A1 (en) * | 2012-06-05 | 2013-12-05 | Iris International, Inc. | Method for determining recurrence or stable disease after treatment for prostate cancer |
WO2014022594A1 (en) * | 2012-07-31 | 2014-02-06 | Daniel Mercola | Stroma biomarkers for prostate cancer prognosis |
CN105917008B (zh) | 2014-01-16 | 2020-11-27 | 启迪公司 | 用于前列腺癌复发的预后的基因表达面板 |
-
2015
- 2015-01-16 CN CN201580004797.5A patent/CN105917008B/zh active Active
- 2015-01-16 EP EP15701928.2A patent/EP3094747B1/en active Active
- 2015-01-16 WO PCT/US2015/011824 patent/WO2015109234A1/en active Application Filing
- 2015-01-16 CN CN202011258642.3A patent/CN112322735A/zh active Pending
- 2015-01-16 CA CA2935720A patent/CA2935720A1/en active Pending
- 2015-01-16 JP JP2016565119A patent/JP6666852B2/ja active Active
- 2015-01-16 US US15/111,946 patent/US10364469B2/en active Active
- 2015-01-16 AU AU2015206336A patent/AU2015206336B2/en active Active
-
2017
- 2017-05-22 HK HK17105173.9A patent/HK1231515A1/zh unknown
-
2019
- 2019-07-29 US US16/524,617 patent/US11098372B2/en active Active
-
2020
- 2020-03-26 AU AU2020202145A patent/AU2020202145A1/en not_active Abandoned
-
2021
- 2021-08-18 US US17/405,686 patent/US20220033915A1/en active Pending
-
2022
- 2022-05-20 AU AU2022203428A patent/AU2022203428A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2017503527A5 (ja) | ||
ES2595410T3 (es) | Biomarcadores de cáncer | |
Waddell et al. | Gene expression profiling of formalin‐fixed, paraffin‐embedded familial breast tumours using the whole genome‐DASL assay | |
Gertz et al. | Distinct properties of cell-type-specific and shared transcription factor binding sites | |
CA2923092C (en) | Assessment of the pi3k cellular signaling pathway activity using mathematical modelling of target gene expression | |
Qin et al. | HPeak: an HMM-based algorithm for defining read-enriched regions in ChIP-Seq data | |
Tang et al. | A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer | |
JP2010500565A5 (ja) | ||
RU2017146154A (ru) | Способы прогнозирования рака предстательной железы | |
CN105121665A (zh) | 使用多重细胞信号传导途径活性的治疗应答的医学预后和预测 | |
CY1114993T1 (el) | Προφιλ εκφρασης γονιδιου για να προβλεπονται εκβασεις καρκινου μαστου | |
MX369628B (es) | Genes nano46 y metodos para predecir el resultado del cancer de mama. | |
JP2017507320A5 (ja) | ||
RU2016138766A (ru) | Способ диагностики колоректального рака из образца кала человека с помощью количественной пцр, праймеров и набора | |
JP2016507233A5 (ja) | ||
CN103390119B (zh) | 一种转录因子结合位点识别方法 | |
JP2017509351A5 (ja) | ||
Chiam et al. | Identification of microRNA biomarkers of response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma using next generation sequencing | |
JP2014503222A (ja) | 結腸直腸がん再発に関する予後のサイン | |
Klimov et al. | Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers | |
Roukos et al. | Multigene assays and isolated tumor cells for early breast cancer treatment: time for bionetworks | |
Alonso‐Dominguez et al. | PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase | |
Liu et al. | Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+: ERα-breast cancer | |
Oliverio et al. | Evolving clinical applications of tissue transcriptomics in kidney disease | |
Sandhu et al. | Meta-analysis of 1,200 transcriptomic profiles identifies a prognostic model for pancreatic ductal adenocarcinoma |